Prof. Dr. med. Thomas Herdegen is deputy director of the Institute for Experimental and Clinical Pharmacology at Kiel University with a research focus on neuropharmacology and pain pharmacology. He has long been an advocate for the establishment of cannabis as a therapeutic option, collaborates on clinical trials with cannabis, and is an editor for a variety of different media outlets.